论文部分内容阅读
目的:分析降钙素原在新生儿败血症早期诊治中的应用。方法:在本次研究中选择2014年3月-2016年我院收治的32例新生儿败血症患者作为研究组,选择同期收治的非感染的32例儿童作为对照组,探究降钙素原在具体诊断中的应用效果。结果:对两组的PCT、CRP、WBC、PLT、Ret等指标进行对比,实践证明,研究组中,患者的各项指标都要比对照组患者的指标高,数据比较具有统计学意义(p<0.05)。结论:对新生儿败血症患者进行降钙素原诊断,其优势明显,研究组和对照组患者的临床指标存在明显差异,可以作为临床诊断指标。
Objective: To analyze the application of procalcitonin in early diagnosis and treatment of neonatal sepsis. Methods: In this study, 32 cases of neonatal sepsis admitted to our hospital from March 2014 to 2016 were selected as the study group, 32 cases of non-infected children treated at the same period were selected as the control group, to explore procalcitonin in specific Diagnostic application effect. Results: The two groups of PCT, CRP, WBC, PLT, Ret and other indicators were compared, the practice proved that the study group, the patient’s indicators were higher than the control group of patients with indicators, the data was statistically significant (p <0.05). Conclusion: The diagnosis of procalcitonin in neonatal sepsis patients has obvious advantages. The clinical indexes in study group and control group are obviously different and can be used as clinical diagnosis index.